The Medicare Advantage (MA) program has long occupied a unique space as a true public-private partnership in federal healthcare. Recent headlines have put MA back in the spotlight, with reports of plans reducing supplemental benefits, exiting certain markets, focusing on margins, and operating under tighter scrutiny. Together, these developments have fueled a perception that the MA program is in trouble. For plans that are newer to the market or operate at a smaller scale, the current environment can feel particularly unsettled. ARTICLE
